- Oops!Something went wrong.Please try again later.
A Relative Strength Rating upgrade for Stratasys shows improving technical performance. Will it continue?
Don't forget about Novavax (NASDAQ: NVAX). Here's why Novavax stock could skyrocket in December. In this case, there could be increased demand for vaccines that are effective against the omicron variant.
Those following along with Clover Health Investments, Corp. ( NASDAQ:CLOV ) will no doubt be intrigued by the recent...
Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.
On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions.
The professor is known for being bullish on stocks, yet even he says trouble’s coming.
Satya Nadella sold 838,584 shares between Nov. 23 and Nov. 24. The move comes a month before Washington state's capital gains tax goes into effect.
Intel (NASDAQ: INTC) started 2021 with a bang, with shares of the chip giant accelerating in the first quarter of the year thanks to news that it may be gaining ground against rival Advanced Micro Devices (NASDAQ: AMD). Shares of Intel are now trading close to the lower end of their 52-week range. Wall Street doesn't seem to be too optimistic about the company's prospects either, as the stock has an average price target of $54, which points toward a tepid upside from current levels.
Two stocks I own and will add to during December are PayPal Holdings (NASDAQ: PYPL) and MercadoLibre (NASDAQ: MELI). PayPal provides a payment platform to process consumer and business transactions. It also owns Venmo, a popular app for sending money; and Honey, the browser add-on that saves customers money through automated coupon searches.
After hitting an all-time high of nearly $300 per share earlier this year, shares of CrowdStrike (NASDAQ: CRWD) have slid sharply recently. Trading at about $225 headed into the company's earnings report later this week, the stock is approximately down 25% from its all-time high. Can tech company's upcoming earnings report help revitalize interest in the stock?
After sliding along with the rest of the stock market on Friday, shares of lithium mining stock Lithium Americas (NYSE: LAC) are rebounding in a big way on Monday -- up 13.6% as of 12:15 p.m. ET. You can thank the friendly analysts at National Bank Financial for that. No sooner had Lithium Americas finished its Friday slide than an analyst at the Canadian investment bank stepped in and reiterated an outperform recommendation on the stock.
Stock futures dropped on Tuesday as volatility resumed after a brief rebound earlier this week, with investors contemplating the impacts of a new coronavirus variant.
If you're a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. The single most persuasive argument against it being too late to buy Viatris is that the company is just getting started. After all, its life as an independent entity started a mere year ago with the merger of Pfizer's generic drugs business, Upjohn, and Mylan.
Sundial Growers (NASDAQ: SNDL) has come a long way since its explosion onto the public scene and its brief tenure as a meme stock. Formerly a small regional marijuana company in Canada, Sundial has effectively leveraged its popularity to become something more than a cannabis seller, and it now has a shot at becoming a serious player in the industry. Rather than prioritizing growing and selling marijuana, Sundial is positioning itself to be a kingmaker and principal investor for smaller cannabis companies in Canada.
Words have power -- as investors discovered to their dismay last week. News of the new omicron variant of COVID-19 shocked the stock market, sending shares of cruise line stocks Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL) (NYSE: CUK), and Norwegian Cruise Line Holdings (NYSE: NCLH) tumbling 10% and more in Friday trading.
It's been a big year for Tesla (NASDAQ: TSLA). An analysis of the company's current momentum and some of the catalysts in place for next year shows that the electric-car maker's vehicle deliveries could continue rising sharply in 2022. Here's why Tesla could grow its deliveries around 50% next year.
Shortly after Sundar Pichai became CEO of Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) in 2015, he boldly proclaimed that his vision was to evolve into an AI-first company. Alphabet's consistent investments to support long-term growth are certainly reflected in its strong financial performance. Although the company competes with other technology behemoths such as Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Netflix (NASDAQ: NFLX), Alphabet's most recent quarterly results lead me to believe that it could very well become the biggest company in the world in terms of market cap in the not-too-distant future, replacing Apple (NASDAQ: AAPL).
Adagio Therapeutics Inc. is riding high after the company said its experimental antibody is likely to be just as effective against the omicron variant of the coronavirus as it is against previous variants. The antibody, a drug called ADG20, affords protection for up to one year, according to the firm.
Growth in its core Chinese e-commerce division, as well as in cloud computing and its international business, are likely to be crucial to Alibaba's stock.
-- in which its stock shed 3.6%, shares of semiconductors star Nvidia (NASDAQ: NVDA) are bouncing back Monday morning, up 2.8% as of 11 a.m. ET. The reason: I suspect investors are shrugging off last week's bad coronavirus news and focusing on some good Nvidia news that got overlooked. Specifically, I mean the news that on Friday analysts at investment bank Bank of America doubled down on their buy rating on Nvidia stock.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ); (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce the publication of the first data on the interaction of the selective serotonin uptake inhibitor (SSRI) escitalopram with the acute response to psilocybin in humans. The publication resulted from a randomized, double-blind, placebo-controlled, crossover pharmacology study in healthy volunteers conducted by the University